These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1077 related items for PubMed ID: 16146835

  • 1. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU, Tartan Z, Terzi S, Kasikcioglu H, Uyarel H, Orhan G, Alper AT, Ciloglu F, Cam N.
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [Abstract] [Full Text] [Related]

  • 2. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
    Samani NJ, O'Toole L, Martin D, Rai H, Fletcher S, Lodwick D, Thompson JR, Morice AH, Channer K, Woods KL.
    J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
    [Abstract] [Full Text] [Related]

  • 3. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
    Ay C, Bencur P, Vormittag R, Sailer T, Jungbauer C, Vukovich T, Mannhalter C, Pabinger I.
    Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
    [Abstract] [Full Text] [Related]

  • 4. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
    Voors AA, van Geel PP, Oosterga M, Buikema H, van Veldhuisen DJ, van Gilst WH.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
    [Abstract] [Full Text] [Related]

  • 5. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
    Philipp CS, Dilley A, Saidi P, Evatt B, Austin H, Zawadsky J, Harwood D, Ellingsen D, Barnhart E, Phillips DJ, Hooper WC.
    Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
    [Abstract] [Full Text] [Related]

  • 6. The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction.
    Seckin D, Ilhan N, Ilhan N, Ozbay Y.
    Clin Biochem; 2006 Jan; 39(1):50-4. PubMed ID: 16303122
    [Abstract] [Full Text] [Related]

  • 7. Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.
    Völzke H, Kleine V, Robinson DM, Grimm R, Hertwig S, Schwahn C, Eckel L, Rettig R.
    Int J Cardiol; 2005 Jan; 98(1):133-9. PubMed ID: 15676177
    [Abstract] [Full Text] [Related]

  • 8. Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification.
    Davutoglu V, Nacak M.
    J Heart Valve Dis; 2005 May; 14(3):277-81. PubMed ID: 15974518
    [Abstract] [Full Text] [Related]

  • 9. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 10. Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease.
    Al-Fakhri N, Linhart RE, Philipp M, Heidt M, Hehrlein FW, Gardemann A, Katz N.
    J Hum Hypertens; 2003 Feb; 17(2):133-8. PubMed ID: 12574792
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism.
    Okura Y, Hayashi K, Shingu T, Kuga Y, Nomura S, Kajiyama G, Nakashima Y, Saku K.
    Coron Artery Dis; 2003 Jun; 14(4):285-91. PubMed ID: 12826927
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-I-converting enzyme (ACE) insertion/deletion polymorphism in Mexican patients with coronary artery disease. Association with the disease but not with lipid levels.
    Vargas-Alarcón G, Zamora J, Sánchez-García S, Rodríguez-Pérez JM, Cardoso G, Posadas-Romero C.
    Exp Mol Pathol; 2006 Oct; 81(2):131-5. PubMed ID: 16764852
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme insertion/deletion polymorphism and retinal artery occlusion.
    Schäfer E, Weger M, Birgül T, Renner W, Stanger O, Steinbrugger I, Schmut O, Temmel W, Haas A.
    Acta Ophthalmol Scand; 2006 Jun; 84(3):305-8. PubMed ID: 16704688
    [Abstract] [Full Text] [Related]

  • 14. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
    Ribichini F, Ferrero V, Matullo G, Feola M, Vado A, Camilla T, Guarrera S, Carturan S, Vassanelli C, Uslenghi E, Piazza A.
    Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
    [Abstract] [Full Text] [Related]

  • 15. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
    Bauters C, Amouyel P.
    Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of angiotensin I converting enzyme gene polymorphism in patients with essential hypertension and coronary artery disease].
    Oshima T, Nakano Y, Matsumoto T, Ozono R, Kambe M, Ishioka N, Sasaki N, Ishibashi K, Matsuura H, Kajiyama G.
    Rinsho Byori; 1997 Feb; 45(2):115-21. PubMed ID: 9120994
    [Abstract] [Full Text] [Related]

  • 17. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure].
    Huang WY, Sun M, Zhou HY, Pei ZF, Yang TL.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):686-9. PubMed ID: 16114558
    [Abstract] [Full Text] [Related]

  • 18. Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677-->T transition in the MTHFR gene.
    Zak I, Niemiec P, Sarecka B, Balcerzyk A, Ciemniewski Z, Rudowska E, Dylag S.
    Acta Biochim Pol; 2003 Dec; 50(2):527-34. PubMed ID: 12833177
    [Abstract] [Full Text] [Related]

  • 19. [Deletion polymorphism of the angiotensin I-converting enzyme gene associates with increased risk for ischemic heart diseases in the Japanese].
    Nakai K, Itoh C, Miura Y, Musya T, Hotta K, Hiramori K.
    Rinsho Byori; 1994 Jul; 42(7):689-94. PubMed ID: 8065033
    [Abstract] [Full Text] [Related]

  • 20. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P, Majkowska L, Kaliszczak R, Safranow K, Adler G, Goracy I.
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.